Form 4 for NTLA Intellia Therapeutics, Inc.
Accepted 2025-07-02 00:00:00 ET · period of report 2025-06-30 · accession 0000950170-25-093302 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2025-07-02 | 2025-06-30+ | NTLA | GOODMAN JESSE | Dir | S - Sale | $9.40 | -3,094 | 25.9K | -11% | -$29.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-01 | S | D | 1,547 | $9.23 | 24,359 | D | — | — | |
| 2 | Common | Common Stock | 2025-06-30 | S | D | 1,547 | $9.56 | 25,906 | D | — | — |